[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"nutrition-assessment\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:nutrition-assessment":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,7,0,[8,50,74,106,143,175,204],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":32,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":40,"lastUpdatePostDateStruct":41,"startDateStruct":44,"completionDateStruct":45,"leadSponsor":47,"locationsCount":4},"100639806","nutritional-status-in-adults-with-diabetic-foot-ulcers-100639806",false,"NCT07621770","Nutritional Status in Adults With Diabetic Foot Ulcers","Nutritional Status in Adults With Diabetic Foot in an Outpatient Wound Clinic: A Feasibility and Pilot Study","NutriDFU-P","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Diagnosed with diabetes type 1 or type 2\n* Presence of one or more DFUs\n* Receiving treatment in a participating outpatient wound clinic\n* Able to provide written informed consent\n\nExclusion Criteria:\n\n* Above ankle amputation of the contralateral leg\n* Current treatment with intravenous antibiotics for acute infection.\n* Current hospitalisation for acute surgical management of the foot ulcer\n* Declining or unable to participate in a telephone follow-up interview.\n* Current long-term enteral (tube feeding) or parenteral nutritional support.\n\nExclusion criteria for bioelectrical impedance analysis (BIA)\n\n\\- Presence of a cardiac pacemaker or other implanted electronic device","ALL","18 Years",{"count":20,"type":21},30,"ESTIMATED","OBSERVATIONAL","This feasibility and pilot study has two aims. The primary aim is to assess the feasibility of collecting clinical, nutritional, and functional data among adults with diabetic foot ulcers (DFUs) who are treated at an outpatient wound clinic. Specifically, the study will evaluate recruitment and inclusion rates, the relevance and clinical utility of selected variables, and assess the completeness and reliability of data collection.\n\nThe secondary aim is to provide a preliminary characterisation of nutritional status, dietary intake, body composition, muscle strength, mobility, and wound-related quality of life, to inform the design and methodology of a future full-scale national study.\n\nDFUs are associated with delayed healing, recurrent infections, reduced quality of life, and increased risk of hospitalization and amputation. These conditions are frequently accompanied by systemic inflammation, impaired circulation, and metabolic disturbances, which may increase nutritional requirements and negatively affect wound healing.\n\nDespite nutrition being recognized as a modifiable factor of ulcer healing, the nutritional status of individuals with DFUs remains insufficiently characterised, and evidence regarding clinically relevant nutritional deficiencies in this population is limited.\n\nParticipants will undergo assessment of height, weight, body composition, handgrip strength, and a 24-hour dietary recall interview during an outpatient clinic visit. Nutritional screening questionnaires and patient-reported measures of appetite, nutritional impact symptoms, mobility, and quality of life will be collected through telephone interviews within one week of the clinical visit.\n\nEligible participants are adults (\\>18 years) who are referred to the outpatient wound clinic with a hard-to-heal foot ulcer. Participants must be able to communicate in Danish or English.",[25,26,27,28,29,30,31],"Diabetic Foot Ulcers (DFU)","Nutrition Assessment","Malnutrition (Calorie)","Ulcer Foot","Dietary Intake Assessment","Bio-Impedance Measurements","Wound Healing",[33,34,35,36,37,38],"DFU","Malnutrition","Wound healing","Nutritional assessment","outpatient","hard-to-heal ulcer","NOT_YET_RECRUITING","2026-05-29",{"date":42,"type":43},"2026-06-02","ACTUAL",{"date":42,"type":21},{"date":46,"type":21},"2026-10-30",{"name":48,"class":49},"Hvidovre University Hospital","OTHER",{"id":51,"slug":52,"hasResults":11,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":4,"eligibilityCriteria":56,"healthyVolunteers":11,"sex":17,"minAge":57,"maxAge":4,"enrollmentInfo":58,"targetDuration":4,"studyType":60,"phases":61,"briefSummary":63,"conditions":64,"keywords":4,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":4},"100632506","impact-of-estimated-weight-and-height-on-nutritional-assessment-in-elderly-100632506","NCT07514572","Impact of Estimated Weight and Height on Nutritional Assessment in Elderly","Accuracy of Estimated Weight and Height in Old Inpatients and Their Impact on Nutritional Assessment","Inclusion Criteria:\n\n* Patients of both sexes with free and informed consent.\n* Age 65 or older (in line with the World Health Organization definition and the recommendations of the ESPEN guidelines for geriatric nutritional assessment).\n\nExclusion Criteria:\n\n* Inability or unwillingness to provide informed consent.\n* Severe cognitive impairment.\n* Language or communication barriers.\n* Clinical or logistical conditions that make objective measurement of weight and\u002For height impossible (e.g., non-transferable bedridden status, clinical instability, risk to the patient).\n* Clinical judgment of unsuitability, at the discretion of the physician responsible for the study","65 Years",{"count":59,"type":21},400,"INTERVENTIONAL",[62],"NA","Recording the exact weight and height should represent a standard practice for all inpatients, as they significantly impact on patients' care, drug dosing and nutritional assessment.\n\nHowever, these measurements are recorded in a small percentage of inpatients and, even worse, they often are estimated by nurses or Physicians, or self-reported by patients. This error may contribute to a wrong nutritional assessment, since the body mass index (BMI) is one of the parameters included in some of the most used nutritional scores.\n\nIn this study the investigators will perform a nutritional assessement, at hospital admission, in a group of inpatients by the mini-nutritional assessment short form (MNA-SF), by means of estimated, self-reported and exact body weight measures.\n\nMoreover, in those subjects with a malnutrition diagnosis (by MNA-SF) the investigators will perform bioimpedence analysis and will evaluate a series of anthropometric measurements offering insights into body composition and distribution of fat and muscle, such as calf, waist and hip circumference.",[26],"2026-04-01",{"date":67,"type":43},"2026-04-07",{"date":69,"type":21},"2026-05-07",{"date":71,"type":21},"2027-05-07",{"name":73,"class":49},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS",{"id":75,"slug":76,"hasResults":11,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":80,"eligibilityCriteria":81,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":82,"targetDuration":4,"studyType":60,"phases":84,"briefSummary":86,"conditions":87,"keywords":90,"overallStatus":95,"whyStopped":4,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":105},"100589390","phase-2-comparison-of-quality-of-life-during-a-flare-of-crohns-disease-treated-with-prednisolone-or-acded-with-pen-in-adult-patients-100589390","NCT06953791","Comparison of Quality of Life During a Flare of Crohn's Disease Treated With Prednisolone or aCDED With PEN in Adult Patients","Comparison of Quality of Life During a Flare of Crohn's Disease Treated With Standard of Care or an Adapted Crohn's Disease Exclusion Diet With Partial Enteral Nutrition in Adult Patients","CONSISTENT","Inclusion Criteria:\n\n* Must be ≥ 18 years at the time of signing the informed consent.\n* Macroscopic small bowel involvement, or isolated large bowel disease confined to the right or transverse colon confirmed by endoscopy\n* Patients with a Crohn's disease activity index (CDAI) of ≥ 150\n* Patients will not be excluded if they have received 5ASA or an immunomodulator for \\> 8 weeks and the dose is stable, or if they start a thiopurine concurrently, as thiopurines are not considered sufficient to induce remission in active disease before 8 weeks as an isolated therapy\n* Understand and voluntarily sign an informed consent document prior to any study related assessments\u002Fprocedures\n* Able to adhere to the study visit schedule and other protocol requirements\n* All subjects must agree to refrain from donating blood while on study drugs\n* All subjects must agree not to share medication.\n* Subject (male or female) is willing to use highly effective contraceptive methods during treatment and for 28 days (male or female) after the end of treatment\n\nExclusion Criteria:\n\n* Patients with with minimal disease activity (CDAI \\\u003C150) or severe disease (CDAI \\>450)\n* Patients who have received corticosteroids of any kind in the previous 4 weeks\n* Patients who have started an immunomodulator in the previous 8 weeks\n* Any current biological or small molecule treatment\n* Isolated large bowel disease iinvolving the recto-sigmoid or descending colon\n* Patients with penetrating disease (abscess or fistula)\n* Active perianal disease\n* Fixed stricture or small bowel obstruction\n* Normal fecal calprotectin\n* Active extraintestinal disease (e.g. joint disease)\n* Patients who have undergone an intestinal resection\n* Sclerosing cholangitis\n* History of hypersensitivity to the investigational medicinal product or to any drug with similar chemical structure or to any excipient present in the pharmaceutical form of the investigational medicinal product.\n* Women during pregnancy and lactation Participation in other clinical trials or observation period of competing trials.",{"count":83,"type":21},52,[85],"PHASE2","Crohn's disease (CD), a type of inflammatory bowel disease (IBD), is on the rise globally. Although medical treatments have advanced, CD still leads to significant health issues due to disease progression and medication side effects. Exclusive enteral nutrition (EEN) is a recommended first-line treatment for pediatric CD, proving more effective than oral corticosteroids without side effects. However, EEN demands strict adherence, making it challenging for patients, particularly adults.\n\nIn 2019, Levine et al. found that a combination of a specific diet (CD exclusion diet, CDED) and partial enteral nutrition (PEN) was as effective as EEN in inducing remission in pediatric patients, with better tolerance and adherence. CDED focuses on whole foods and aims to minimize harmful dietary components affecting the gut.\n\nIn clinical practice, an adapted CDED (aCDED) has been used to provide more food choices, but it lacks validation in clinical trials. An aCDED that considers regional and seasonal food variations could enhance patient adherence and align with modern dietary preferences.\n\nThis study aims to compare the quality of life during a flare up of Crohn's disease treated with standard of care or an adapted Crohn's disease exclusion diet with partial enteral nutrition in adult patients.",[88,26,89],"Crohn Disease","Diet Therapy",[91,92,93,94],"Nutrition","crohn disease","diet therapy","consistent","RECRUITING","2026-02-02",{"date":98,"type":43},"2026-02-05",{"date":100,"type":43},"2026-02-01",{"date":102,"type":21},"2028-02-01",{"name":104,"class":49},"University Hospital Tuebingen",1,{"id":107,"slug":108,"hasResults":11,"nctId":109,"briefTitle":110,"officialTitle":111,"acronym":4,"eligibilityCriteria":112,"healthyVolunteers":11,"sex":17,"minAge":57,"maxAge":4,"enrollmentInfo":113,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":115,"conditions":116,"keywords":125,"overallStatus":95,"whyStopped":4,"lastUpdateSubmitDate":134,"lastUpdatePostDateStruct":135,"startDateStruct":137,"completionDateStruct":139,"leadSponsor":141,"locationsCount":105},"100592034","frailty-and-muscle-strength-tests-in-older-adults-undergoing-major-surgery-100592034","NCT06988176","Frailty and Muscle Strength Tests in Older Adults Undergoing Major Surgery","Feasibility and Correlation of Functional Muscle Strength Tests and Objective Frailty Measures With Clinical Frailty Scale in Patients Undergoing Major Surgery","Inclusion Criteria:\n\nParticipants may be eligible for this study if they meet the following conditions:\n\n* Age 65 years or older.\n* Scheduled for elective (planned, non-emergency) major abdominal surgery, including colorectal, hepatobiliary, gynecologic, or urologic procedures.\n* Able to attend a routine preoperative evaluation visit.\n* Able and willing to complete brief assessments for muscle strength, walking, breathing strength, memory, and nutrition.\n\nExclusion Criteria:\n\nParticipants will not be eligible for the study if they have any of the following conditions:\n\n* Surgery is an emergency procedure.\n* Unable to walk independently (for example, dependent on a wheelchair or bed-bound).\n* Significant cognitive impairment that prevents understanding or completing study tests.",{"count":114,"type":21},100,"The goal of this observational study is to learn if simple tests for frailty and muscle strength can help predict which older adults (age 65 and older) are at higher risk for problems after major abdominal surgery.\n\nThe main questions it aims to answer are:\n\n* Do measures of frailty and muscle strength, taken before surgery, predict complications after surgery?\n* Can these tests be easily done during a routine pre-surgical visit?\n\nParticipants will:\n\n* Complete brief tests measuring muscle strength, breathing strength, physical function, nutrition status, body composition, and memory during a regular pre-surgical clinic appointment.\n* Allow researchers to review their medical records 30 and 90 days after surgery to identify any complications or health problems.",[117,118,119,120,121,26,122,123,124],"Frailty","Sarcopenia","Sarcopenia in Elderly","Muscle Strength","Post Operative Complications","Risk Assessment","Elderly (People Aged 65 or More)","Hand Strength",[117,126,127,128,124,129,130,122,26,131,132,133],"sarcopenia","elective abdominal surgery","Muscle strength","Inspiratory muscle strength","Post operative complications","Elderly patients","Cognitive Function","Physical functional performance","2026-01-27",{"date":136,"type":43},"2026-01-28",{"date":138,"type":43},"2025-06-19",{"date":140,"type":21},"2026-08",{"name":142,"class":49},"University of North Carolina, Chapel Hill",{"id":144,"slug":145,"hasResults":11,"nctId":146,"briefTitle":147,"officialTitle":147,"acronym":4,"eligibilityCriteria":148,"healthyVolunteers":149,"sex":17,"minAge":150,"maxAge":151,"enrollmentInfo":152,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":154,"conditions":155,"keywords":162,"overallStatus":95,"whyStopped":4,"lastUpdateSubmitDate":166,"lastUpdatePostDateStruct":167,"startDateStruct":169,"completionDateStruct":171,"leadSponsor":173,"locationsCount":105},"100610171","assessment-and-educational-intervention-to-reduce-ultra-processed-food-consumption-in-pediatric-patients-with-ibd-100610171","NCT07224113","Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD","Inclusion Criteria:\n\n* Diagnosis of IBD (Crohn's disease, Ulcerative Colitis, IBD-U) for at least 3 months\n* Age 10 through \\\u003C 22 years at the time of enrollment (i.e., up to the day before the 22nd birthday)\n* Followed by a gastroenterologist at Connecticut Children's\n* IBD in clinical remission based on calculated PUCAI score \\\u003C10 or PCDAI score of \\\u003C10\n* Receiving medical infusions at CCMC Infusion Center as part of IBD treatment\n* Participants must be on full oral intake and not have major dietary restrictions or require oral nutrition supplements\n\nExclusion Criteria:\n\n* Following a medically prescribed or restrictive diet such as Crohn's Disease Exclusion Diet (CDED), ketogenic diet, Specific Carbohydrate Diet (SCD), low FODMAP diet, gluten-free diet, paleo, or Whole30.\n* Receiving any nutrition through feeding tubes (including nasogastric \\[NG\\], nasojejunal \\[NJ\\], gastrostomy \\[G\\], or gastrojejunostomy \\[GJ\\] tubes)\n* History of bowel surgery within 3 months of study start affecting ability to sustain normal enteral intake\n* Non-English-speaking participants (as translation and short-form consent processes will not be used for this study)",true,"10 Years","21 Years",{"count":153,"type":21},120,"This study explores whether simple nutrition education can help children and teens with inflammatory bowel disease (IBD) eat fewer ultra-processed foods (UPFs). UPFs include packaged snacks, sugary drinks, and fast food-items that are high in added sugars, fats, and artificial ingredients. Participants will complete online food recalls to measure what they eat and will then receive either nutrition handouts alone or handouts plus a short educational video about UPFs. Researchers will compare changes in UPF intake between the two groups after several weeks and ask families how useful and acceptable they found the materials. The goal is to identify an effective, practical way to support healthier eating habits and long-term gut health in pediatric IBD.",[156,157,158,159,160,26,161],"IBD","Crohn Disease (CD)","Ulcerative Colitis (UC)","Inflammatory Bowel Disease (IBD)","Ultra Processed Food","DGBI",[156,163,88,164,165],"Inflammatory Bowel Disease","Ulcerative Colitis","Ultra processed food","2025-11-17",{"date":168,"type":43},"2025-11-19",{"date":170,"type":43},"2025-11-10",{"date":172,"type":21},"2026-07-30",{"name":174,"class":49},"Connecticut Children's Medical Center",{"id":176,"slug":177,"hasResults":11,"nctId":178,"briefTitle":179,"officialTitle":180,"acronym":181,"eligibilityCriteria":182,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":183,"enrollmentInfo":184,"targetDuration":4,"studyType":60,"phases":186,"briefSummary":188,"conditions":189,"keywords":191,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":195,"lastUpdatePostDateStruct":196,"startDateStruct":198,"completionDateStruct":200,"leadSponsor":202,"locationsCount":4},"100609208","phase-3-pert-in-acute-necrotizing-pancreatitis-100609208","NCT07211568","PERT in Acute Necrotizing Pancreatitis","Effect of Pancreatic Enzyme Replacement Therapy on Nutrition in Acute Pancreatitis: A Multicenter Double Blinded Randomised Placebo Controlled Trial.","PERT-ANP","Inclusion Criteria:\n\n* Patients diagnosed with AP according to the Revised Atlanta Classification diagnostic criteria\n* Index episode of acute pancreatitis with at least 50% pancreatic parenchymal necrosis and greater than at least 10% loss of pre pancreatitis body weight at the time of screening\n* Within 28 days of onset of disease\n* Age 18-60 years\n* Both genders\n\nExclusion Criteria:\n\n* Underlying chronic pancreatitis\n* Recurrent acute pancreatitis\n* Pancreatic cancer\n* Patients being discharged with NJ tubes\n* Pregnancy and lactation\n* Inability to give informed consent.","60 Years",{"count":185,"type":21},188,[187],"PHASE3","In this multicenter, double blinded, placebo-controlled, 1:1 parallel group RCT, we propose to evaluate the impact of pancreatic exocrine replacement therapy on patients with acute necrotizing pancreatitis (ANP). We will include patients of 18-60yrs age and both genders with \\>50% pancreatic parenchymal necrosis and \\>10% loss of body weight.\n\nThe primary outcome measure is change in BMI at 3 months after enrolment. The intervention will include pancreatic enzyme consisting of 25000 IU of lipase and similar appearing placebo.",[190,26],"Acute Pancreatitis Necrotizing",[192,193,194],"Nutrition in AP","PERT in AP","pancreatic exocrine insufficiency","2025-09-30",{"date":197,"type":43},"2025-10-08",{"date":199,"type":21},"2025-10-01",{"date":201,"type":21},"2027-07-31",{"name":203,"class":49},"Asian Institute of Gastroenterology, India",{"id":205,"slug":206,"hasResults":11,"nctId":207,"briefTitle":208,"officialTitle":209,"acronym":210,"eligibilityCriteria":211,"healthyVolunteers":11,"sex":17,"minAge":183,"maxAge":4,"enrollmentInfo":212,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":214,"conditions":215,"keywords":231,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":242,"lastUpdatePostDateStruct":243,"startDateStruct":245,"completionDateStruct":247,"leadSponsor":249,"locationsCount":4},"100590537","project-icope-brazil-assessment-of-intrinsic-capacity-in-brazilian-older-adults-100590537","NCT06968702","Project ICOPE Brazil: Assessment of Intrinsic Capacity in Brazilian Older Adults","Project ICOPE Brazil: Assessment of Intrinsic Capacity in Older Adults as a Basis for Implementation of the WHO ICOPE Strategy in the Unified Health System.","ICOPE-BR","Inclusion Criteria:\n\n* People aged ≥ 60 years, with no age limit;\n* Being registered (with available contact information) in the participating health care units;\n* Being available to go in person to the data collection sites for the assessments.\n\nExclusion criteria\n\n* Inability to access the data collection site;\n* Severe neurologic and\u002For cognitive impairments that preclude interaction with the evaluators to complete the proposed tests and data collections;\n* Advanced serious illness or under palliative care:\n\nClinical Frailty Scale (CFS)20 score of 8 (severely frail) or 9 (terminally ill).",{"count":213,"type":21},3838,"The ICOPE Brazil study aims to understand aging trajectories in Brazil, especially healthy aging trends based on intrinsic capacity, a collective of mental and physical capacities one may have to maintain their functional ability to execute daily life activities. Tests and questionnaires will be applied to collect data on mobility capacity, cognitive capacity, nutritional status, vision, and hearing (sensorial) capacities, and mental health. These assessments are in consonance with what the World Health Organization proposed in the Integrated Care for Older People Program (ICOPE). Participants will be followed up for three years, and the primary outcomes of interest are loss of intrinsic capacity, mobility impairment, cognitive impairment, incident depressive symptoms, loss of functional ability, incident frailty, incident sarcopenia, incident falls, hospitalization, multimorbidity, and mortality.",[216,117,217,218,219,220,221,222,223,224,225,226,227,228,229,230,26],"Intrinsic Capacity","Aging","Healthy Aging","Functional Ability","Mobility and Independence","Cognitive Ability, General","Cognitive Impairment","Sensory Hearing Loss","Sensory Deficits","Visual Acuity","Visual Impairment","Mood Disorders","Depressive Symptoms","Vitality","Nutritional Risk",[232,219,233,234,235,117,222,236,237,229,238,239,240,241],"Instrinsic Capacity","ICOPE","Aging trends","Older Adults","Mobility","Sensory","Psychological","Cohort","healthy aging","public health","2025-05-05",{"date":244,"type":43},"2025-05-13",{"date":246,"type":21},"2025-05-15",{"date":248,"type":21},"2029-11",{"name":250,"class":49},"University of Sao Paulo"]